New Research Reports

JK Cement (JKCE) has embarked on an express growth track, offering strong visibility of 16% CAGR capacity creation over FY25-30 (vs. FY15–25’s 9%).

*over or under performance to benchmark index In Q1FY25, inpatient volume was up 15.3% YoY and 6.22% QoQ, while outpatient KIMS ramped up its capacity to 5,499 beds in Q1FY26. However, occupancy...

In Q1FY26, Krsnaa Diagnostics (Krsnaa) reported revenue of ?193 crores, up 13.4% YoY. EBITDA improved 20.5% YoY to ?51.4 crores, resulting in a margin expansion to 26.6% in Q1FY26 vs. 25.1% in Q1FY25, showing efficiency, cost controls, and disciplined execution across PPP and retail units.

HCG is poised to deliver strong top-line growth over the next 23 years, supported by improvements in ARPOB and ongoing bed additions. However, profitability recovery may be gradual given the debt-funded nature of recent capex. Management has indicated plans for a capital infusion, which could help ease the interest burden. With KKR as the new promoter, the business is expected to undergo transformation, enhancing growth and operational efficiencies. Considering the elevated debt levels, we retain our Hold...

ting the drag on margins. Resultantly, gross margins stood at 29.1%, registering a 68 bps expansion. Employee costs fell to 13.2% from 15.1% in the same quarter last year, thereby bolstering an EBITDA margin expansion of 194 bps to stand at 13.2%. Profit After Tax registered 31% YoY growth to stand at Rs.805.50cr. Despite higher depreciation (32% increase), finance costs (35% increase), and a jump...

Consumption Boost / Discretionary Spending Upside: Sai Silk (Kalamandir) is well positioned to benefit from the upcoming festival and wedding season, which is expected to drive strong demand for ethnic wear across its stores.

Quarterly Update Q1FY26

Recommend a BUY rating on the stock with a TP of Rs 870/share, implying an upside of 10% from the CMP.

Innovation and premiumization success demand a premium